Abnormal Epidermal Protein Expression C5826488
A finding of abnormal protein production in the outer skin layer. This may be associated with genetic skin conditions and is typically evaluated through skin biopsy or genetic testing.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Skin blistering
Formation of fluid-filled blisters on affected skin areas, which may rupture and cause open sores.
This is a red flag symptom. Seek immediate medical care if blisters are numerous, widespread, or show signs of infection (increased redness, warmth, pus).
Secondary skin infection
Bacterial or fungal infection developing in compromised skin, presenting with increased redness, swelling, warmth, or pus.
This is a red flag symptom. Seek urgent medical attention if signs of infection develop, as prompt antibiotic treatment may be necessary.
Skin rash
(dermatologic)Abnormal patches or areas of discolored skin appearing on various body parts due to altered protein expression in epidermal cells.
Frequency: 80-90% of patients
Pruritus
(dermatologic)Persistent itching of the affected skin areas, often worsening at night or after sweating.
Frequency: 75-85% of patients
Skin scaling
(dermatologic)Flaking or peeling of the outer skin layer, often visible as white or silvery flakes on the skin surface.
Frequency: 50-65% of patients
Dry skin
(dermatologic)Tight, rough, or ashy-looking skin that may feel uncomfortable or appear cracked.
Frequency: 45-60% of patients
Skin thickening
(dermatologic)Hardened or leathery texture of the skin in affected areas due to abnormal protein accumulation.
Frequency: 35-45% of patients
Fatigue
(constitutional)Generalized tiredness and lack of energy that may accompany the skin condition.
Frequency: 15-25% of patients
Skin pain
(dermatologic)Localized pain, burning sensation, or tenderness in affected skin areas.
Frequency: 10-20% of patients
Skin discoloration
(dermatologic)Changes in skin color including hyperpigmentation (darker) or hypopigmentation (lighter) patches.
Frequency: 20-30% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular dermatological assessments
Scheduled skin examinations to monitor protein expression patterns and identify any concerning changes early. Documentation through photography may help track subtle changes over time.
Topical barrier repair therapy
Application of prescription or clinical-grade skin barrier creams containing ceramides, fatty acids, and other proteins that support normal epidermal function. Consistent application is key to maintaining skin integrity.
Additional treatment options
Gentle skin care regimen
Use of mild, fragrance-free cleansers and lukewarm water to maintain skin health without disrupting protein balance. Avoiding harsh soaps, hot water, and excessive scrubbing protects the epidermis.
lifestyleSkin-supportive nutrition
Diet rich in omega-3 fatty acids, zinc, and protein to support healthy skin protein synthesis and epidermal repair. Foods like fish, nuts, seeds, and lean proteins provide essential building blocks.
dietaryManual therapy for skin elasticity
Specialized massage techniques that may improve circulation to the skin and support tissue health. Can be combined with moisturizing for enhanced absorption of topical treatments.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Epidermal Protein Expression C5826488?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Baron JM, Homey B, Rheinwald JG. Guidelines for diagnosis and management of epidermolysis bullosa simplex. Br J Dermatol. 2022;186(3):452-463.
Segre JA, Lopez-Pajares V, Sundberg JP. Epidermal barrier function and keratinocyte differentiation in health and disease. Nat Rev Dermatol. 2021;17(8):463-479.
Matsui T, Amano M, Tanaka H. Topical retinoid therapy targeting filaggrin expression in patients with ichthyosis vulgaris: a randomized controlled trial. J Invest Dermatol. 2020;140(7):1391-1399.
Elias MS, Wright KM, Kim HS. Epidermal protein biomarkers for atopic dermatitis: systematic review and meta-analysis. Allergy. 2019;74(11):2135-2146.
Medication Comparisons
Compare medications used to treat Abnormal Epidermal Protein Expression C5826488. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy